In Vivo Tracking of Cell Viability for Adoptive Natural Killer Cell‐Based Immunotherapy by Ratiometric NIR‐II Fluorescence Imaging
- 16 July 2021
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (38) , 20888-20896
Abstract
The therapeutic efficacy of natural killer (NK) cells‐based immunotherapy is greatly related with the survival of transplanted NK cells. However, no effective strategy was reported to monitor NK cell viability in adoptive immunotherapy in vivo. Herein, we develop a ratiometric NIR‐II fluorescence imaging strategy to quantitively track and visualize the adoptive NK cell viability in vivo in real‐time. The nanoprobe consists of lanthanide‐based down‐conversion nanoparticles (DCNP) coated with IR786s, a reactive oxygen species (ROS) sensitive to NIR dye, which was directly labeled with NK cells. Upon cell death, the excessive ROS generation occurred within NK cells, along with IR786s degradation, turning on NIR‐II fluorescent signal at 1550 nm of DCNP under 808‐nm excitation, while the fluorescent signal at 1550 nm of DCNP under 980‐nm excitation was stable. Such an intracellular ROS‐induced ratiometric NIR‐II fluorescent signal was validated to correlate well with NK cell viability in vivo. Using this nanoreporter, we further demonstrated that co‐treatment with IL‐2, IL‐15, and IL‐21 could improve NK cell viability in vivo, achieving enhanced immunotherapy for orthotopic hepatocellular carcinoma. Overall, this strategy allows for longitudinal and quantitative tracking of NK cell viability in NK cell‐based immunotherapy.Keywords
Funding Information
- National Natural Science Foundation of China (61727823, 21874024, 22027805)
- Natural Science Foundation of Fujian Province (2020J011152, 2020J02010)
This publication has 28 references indexed in Scilit:
- Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia PatientsClinical Cancer Research, 2017
- NK cell-based immunotherapy for cancerSeminars in Immunology, 2017
- In vivo gastrointestinal drug-release monitoring through second near-infrared window fluorescent bioimaging with orally delivered microcarriersNature Communications, 2017
- Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian CancerStem Cells, 2015
- Enhancing Hematopoietic Stem Cell Transplantation Efficacy by Mitigating Oxygen ShockCell, 2015
- Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma PatientsJournal of Immunotherapy, 2015
- NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptorsNature Medicine, 2012
- Fungal cell wall agents suppress the innate inflammatory cytokine responses of human peripheral blood mononuclear cells challenged with lipopolysaccharide in vitroInternational Immunopharmacology, 2011
- SBDS-deficiency results in deregulation of reactive oxygen species leading to increased cell death and decreased cell growthPediatric Blood & Cancer, 2010
- Development and Application of a Near-Infrared Fluorescence Probe for Oxidative Stress Based on Differential Reactivity of Linked Cyanine DyesJournal of the American Chemical Society, 2010